Related Experiment Videos
Ocular motility in Parkinson's disease
Summary
Parkinson's disease patients commonly experience visual issues like asthenopia and convergence insufficiency. These visual problems are more frequent in Parkinson's patients than in healthy individuals.
Area of Science:
- Ophthalmology
- Neurology
- Neuroscience
Background:
- Parkinson's disease (PD) is linked to visual system abnormalities affecting both afferent and efferent pathways.
- Reported visual findings in PD include blepharospasm, reduced blinking, lid opening apraxia, visual neglect, reduced vergence, reduced upgaze, and blurred vision.
- Systematic investigation into the association, duration, severity, and treatment of these visual findings in PD is lacking.
Purpose of the Study:
- To systematically investigate the prevalence and characteristics of visual complaints and ocular abnormalities in patients with Parkinson's disease.
- To compare the frequency of visual issues in Parkinson's disease patients with an age-matched control group.
Main Methods:
- Prospective examination of 39 Parkinson's disease patients and 39 age-matched controls.
- Data collection included visual complaints, Parkinson's disease severity (Hoehn and Yahr Scale), disease duration, pharmacologic therapy, visual acuity, ocular motility, accommodation, convergence amplitudes, and near point of convergence.
Main Results:
- Parkinson's disease patients reported significantly more asthenopia, upgaze deficiency, and convergence insufficiency compared to controls.
- Mean visual acuity was poorer in Parkinson's patients (20/39) than in controls (20/28).
- The frequency of ocular abnormalities was not associated with disease duration.
Conclusions:
- Visual complaints are significantly more prevalent in Parkinson's disease patients compared to age-matched controls.
- Increasing Parkinson's disease severity correlates with a higher incidence of convergence insufficiency and decreased visual acuity.
- Ocular abnormalities in Parkinson's disease are not directly related to the duration of the illness.